Multi‐Enzyme Mimetic Microneedles with Spatiotemporal Control: Eradicating Biofilms, Resolving Oxidative Stress, and Revascularizing Diabetic Wounds
Small · 2025
DOI: 10.1002/smll.202505277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Jing Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science and Engineering, Zhejiang University of Technology, Hangzhou, 310014, P. R. China. Hauptthemen laut MEDLINE: Biomimetic Materials, Oxidative Stress, Wound Healing, Hyperthermia, Induced. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Diabetic wound healing remains clinically challenging due to persistent oxidative stress and dysregulated inflammation caused by the pathological microenvironment, particularly excessive reactive oxygen species (ROS). A near‐infrared (NIR)‐responsive multifunctional microneedle system (Res@ZIF‐67/Ce 0.1 Mn 0.9 ‐MMON, RZCM) integrating antioxidant, antibacterial, and angiogenic functionalities is developed. The microneedle substrate incorporates Ce 0.1 Mn 0.9 ‐MMON nanoparticles that synergistically exert antibacterial effects through peroxidase‐mimetic activity and NIR‐induced photothermal hyperthermia, while concurrently mimicking superoxide dismutase and catalase activities to scavenge ROS and alleviate hypoxia. The microneedle tips encapsulate pH‐responsive Res@ZIF‐67 nanoparticles that release cobalt ions (Co 2+ ) and resveratrol in acidic environments, cooperatively stabilizing hypoxia‐inducible factor 1α (HIF‐1α) under normoxic conditions to promote angiogenesis. In vivo evaluations demonstrate that RZCM accelerates diabetic wound healing through coordinated mechanisms: photothermal bacterial eradication, ROS scavenging (85.7% reduction), macrophage M2 polarization (2.3 fold increase), HIF‐1α‐mediated neovascularization (2.1 fold higher CD31 density), and enhanced collagen remodeling (78.4% increased collagen I/III ratio). This multifunctional system achieves complete epithelialization within 14 days, outperforming conventional treatments. By integrating multi‐enzyme mimetic nanomaterials with microenvironment‐responsive drug delivery, RZCM establishes a novel therapeutic paradigm for chronic wound management, demonstrating significant translational potential for diabetic wound care through synergistic regulation of oxidative, inflammatory, and angiogenic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Materials Science and Engineering, Zhejiang University of Technology, Hangzhou, 310014, P. R. China.
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer…
ORCID-Profile: Jing Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Zhang, J., Luo, X., Hu, Y., Gao, B., Tang, X., Fang, S., Ou, B., Sheng, X., Su, J., & Feng, J. (2025). Multi‐Enzyme Mimetic Microneedles with Spatiotemporal Control: Eradicating Biofilms, Resolving Oxidative Stress, and Revascularizing Diabetic Wounds. Small. https://doi.org/10.1002/smll.202505277
Vancouver
Zhang J, Luo X, Hu Y, Gao B, Tang X, Fang S, et al. Multi‐Enzyme Mimetic Microneedles with Spatiotemporal Control: Eradicating Biofilms, Resolving Oxidative Stress, and Revascularizing Diabetic Wounds. Small. 2025. doi:10.1002/smll.202505277
BibTeX
@article{Zhang2025,
author = {Zhang, Jing and Luo, Xinxin and Hu, Yisheng and Gao, Bicong and Tang, Xuying and Fang, Sisi and Ou, Bingqian and Sheng, Xiaopeng and Su, Jinshuang and Feng, Jie},
title = {Multi‐Enzyme Mimetic Microneedles with Spatiotemporal Control: Eradicating Biofilms, Resolving Oxidative Stress, and Revascularizing Diabetic Wounds},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202505277}
}
EUVIMED